These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33511656)

  • 1. A systemic review of intravenous immunoglobulin G treatment in women with recurrent implantation failures and recurrent pregnancy losses.
    Saab W; Seshadri S; Huang C; Alsubki L; Sung N; Kwak-Kim J
    Am J Reprod Immunol; 2021 Apr; 85(4):e13395. PubMed ID: 33511656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment.
    Sung N; Khan SA; Yiu ME; Jubiz G; Salazar MD; Skariah A; Dambaeva S; Kwak-Kim J
    J Reprod Immunol; 2021 Nov; 148():103369. PubMed ID: 34492567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
    Sapir T; Carp H; Shoenfeld Y
    Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss.
    Kim DJ; Lee SK; Kim JY; Na BJ; Hur SE; Lee M; Kwak-Kim J
    Am J Reprod Immunol; 2014 May; 71(5):441-50. PubMed ID: 24645850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL).
    Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Afkham A; Danaii S; Abdollahi-Fard S; Heidari L; Jadidi-Niaragh F; Younesi V; Nouri M; Yousefi M
    Biomed Pharmacother; 2017 Aug; 92():1095-1102. PubMed ID: 28622710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
    Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
    Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of IVIG therapy in pregnancy and live birth rate of women with recurrent implantation failure (RIF): A systematic review and meta-analysis.
    Abdolmohammadi-Vahid S; Pashazadeh F; Pourmoghaddam Z; Aghebati-Maleki L; Abdollahi-Fard S; Yousefi M
    J Reprod Immunol; 2019 Sep; 134-135():28-33. PubMed ID: 31425838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.
    Ramos-Medina R; García-Segovia A; Gil J; Carbone J; Aguarón de la Cruz A; Seyfferth A; Alonso B; Alonso J; León JA; Alecsandru D; Meliá E; Carrillo de Albornoz E; Ordoñez D; Santillán I; Verdú V; Garcia Ruiz de Morales JM; López-Hoyos M; López Larios A; Sampalo A; Caballero P; Ortiz Quintana L; Fernández-Cruz E; Sánchez-Ramón S
    Am J Reprod Immunol; 2014 May; 71(5):458-66. PubMed ID: 24612159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.
    Lee SK; Kim JY; Han AR; Hur SE; Kim CJ; Kim TH; Cho BR; Han JW; Han SG; Na BJ; Kwak-Kim J
    Am J Reprod Immunol; 2016 Jan; 75(1):59-68. PubMed ID: 26510488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
    Yang X; Meng T
    J Immunol Res; 2020; 2020():6672865. PubMed ID: 33426092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralipid treatment for women with reproductive failures.
    Coulam CB
    Am J Reprod Immunol; 2021 Apr; 85(4):e13290. PubMed ID: 32567756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial.
    Nørgaard-Pedersen C; Nielsen K; Steffensen R; Eriksen L; Jørgensen MM; Kesmodel US; Christiansen OB
    BMJ Open; 2022 Sep; 12(9):e064780. PubMed ID: 36137638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with intravenous immunoglobulin in patients with recurrent pregnancy loss: An update.
    Christiansen OB; Kolte AM; Krog MC; Nielsen HS; Egerup P
    J Reprod Immunol; 2019 Jun; 133():37-42. PubMed ID: 31238263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility.
    Han AR; Ahn H; Vu P; Park JC; Gilman-Sachs A; Beaman K; Kwak-Kim J
    Am J Reprod Immunol; 2012 Nov; 68(5):418-27. PubMed ID: 22835220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of intravenous immunoglobulin therapy (IVIG) in pregnant patients with recurrent spontaneous abortions].
    Sipak-Szmigiel O; Ronin-Walknowska E; Mikłaszwicz A
    Ginekol Pol; 2003 May; 74(5):350-5. PubMed ID: 12931461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
    Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
    Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does immunotherapy for treatment of reproductive failure enhance live births?
    Coulam CB; Acacio B
    Am J Reprod Immunol; 2012 Apr; 67(4):296-304. PubMed ID: 22340745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory effect of intravenous immunoglobulin on Th17/Treg cell balance in women with unexplained recurrent spontaneous abortion.
    Muyayalo KP; Li ZH; Mor G; Liao AH
    Am J Reprod Immunol; 2018 Oct; 80(4):e13018. PubMed ID: 29984444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin.
    Stricker RB; Steinleitner A; Bookoff CN; Weckstein LN; Winger EE
    Fertil Steril; 2000 Mar; 73(3):536-40. PubMed ID: 10689009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.